Quinto Resources sold its interests in the Monster Lake property
September 04 2020 - 5:00PM
Quinto Resources Inc. ("Quinto") (TSXV: QIT) is pleased to announce
that it has entered into a property acquisition agreement dated
August 12, 2020 with Tomagold Corporation (“Tomagold”) (TSXV: LOT),
and would also like to provide an update with respect to the
purchase of all issued and outstanding shares of Verdélite
Sciences, Inc. (“Verdélite Sciences”) and Verdélite Property
Holdings, Inc. (“Verdélite Property”).
Monster Lake Property
Tomagold acquired the 2.5% interest held by
Quinto in the Monster Lake property for a cash payment of $250,000
and the return of 750,000 shares of Quinto held by TomaGold. The
closing of the transaction took place on August 26, 2020.
Purchase of Verdélite Sciences and Verdélite
Property
On August 11, 2020 Quinto announced the
execution of a share purchase agreement among Emerald Health
Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) and
itself dated July 30, 2020 (the "Agreement") regarding the
sale of all of the issued and outstanding shares of Verdélite
Siences and Verdélite Property (the “Transaction”).
The parties were not able to close on or before
August 31, 2020 as stated in the previous press release,
nevertheless, they are currently working together towards the
purpose of closing the Transaction in a timely fashion at an early
date, subject to the TSX Venture Exchange’s (the “TSXV”)
approval.
Quinto will require the approval of its
shareholders to complete the Transaction and will call a
shareholder meeting, subject to the TSXV approval.
A further press release will be disseminated
upon closing of the Transaction in accordance with the policies of
the TSXV.
About Quinto Resources Inc.
Quinto Resources Inc. (TSXV: QIT) is a Canadian
gold exploration corporation.
Please visit www.quintocorp.com for more information or
contact:
Marcel BergeronChief Financial
Officer
(514) 232-3344marcel.bergeron1@videotron.ca
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release. The TSX Venture Exchange
Inc. has in no way passed upon the merits of the proposed
Transaction and has neither approved nor disapproved the contents
of this news release.
Cautionary Note Regarding Forward-Looking
Statements: Certain statements made in this press release that are
not historical facts are forward-looking statements and are subject
to important risks, uncertainties and assumptions, both general and
specific, which give rise to the possibility that actual results or
events could differ materially from our expectations expressed in
or implied by such forward-looking statements. Such statements
include: the completion of the Transaction and the timing thereof.
Completion of the Transaction is subject to a number of conditions,
including but not limited to, TSXV acceptance and if applicable,
disinterested shareholder approval. Where applicable, the
Transaction cannot close until the required shareholder approval is
obtained. There can be no assurance that the Transaction will be
completed as proposed or at all.
Investors are cautioned that, except as
disclosed in the management information circular to be prepared in
connection with the Transaction, any information released or
received with respect to the Transaction may not be accurate or
complete and should not be relied upon. Trading in the securities
of Quinto should be considered highly speculative.
We cannot guarantee that any forward-looking
statement herein will materialize, and readers are cautioned not to
place undue reliance on these forward-looking statements. These
forward-looking statements involve risks and uncertainties related
to, among other things, changes of law and regulations; changes of
government; failure to obtain regulatory approvals or Quinto
shareholder approval; failure of Quinto to obtain necessary
financing; failure to obtain third party consents; results of
production and sale activities; regulatory changes; changes in
prices and costs of inputs; demand for products; failure of
counter-parties to perform contractual obligations; as well as the
risk factors described in Emerald’s annual information form and
other regulatory filings. The forward-looking statements contained
in this press release represent our expectations as of the date
hereof. Forward-looking statements are presented for the purpose of
providing information about management's current expectations and
plans and allowing investors and others to obtain a better
understanding of our anticipated operating environment. Readers are
cautioned that such information may not be appropriate for other
purposes.
Emerald Health Therapeut... (TSXV:EMH)
Historical Stock Chart
From Oct 2024 to Nov 2024
Emerald Health Therapeut... (TSXV:EMH)
Historical Stock Chart
From Nov 2023 to Nov 2024